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ABSTRACT
Objective A proportion of patients with suspected
ST-elevation myocardial infarction (STEMI) presenting for
primary percutaneous coronary intervention (PPCI) do
not have obstructive coronary disease and other
conditions may be responsible for their symptoms and
ECG changes. In this study, we set out to determine the
prevalence and aetiology of alternative diagnoses in a
large PPCI cohort as determined with multimodality
imaging and their outcome.
Methods From 2009 to 2012, 5238 patients with
suspected STEMI were referred for consideration of PPCI.
Patients who underwent angiography but had no culprit
artery for revascularisation and no previous history of
coronary artery disease were included in the study.
Troponin values, imaging ﬁndings and all-cause mortality
were obtained from hospital and national databases.
Results A total of 575 (13.0%) patients with a mean
age of 58±15 years (69% men) fulﬁlled the inclusion
criteria. A speciﬁc diagnosis based on imaging was
made in 237 patients (41.2%) including
cardiomyopathies (n=104, 18%), myopericarditis (n=48,
8.4%), myocardial infarction/other coronary abnormality
(n=27, 4.9%) and severe valve disease (n=23, 4%).
Pulmonary embolism and type A aortic dissection were
identiﬁed in seven (1.2%) and four (0.7%) cases
respectively. A total of 40 (7.0%) patients died over a
mean follow-up of 42.6 months.
Conclusions A variety of cardiac and non-cardiac
conditions are prevalent in patients presenting with
suspected STEMI but culprit-free angiogram, some of
which may have adverse outcomes. Further imaging of
such patients could thus be useful to help in appropriate
management and follow-up.
INTRODUCTION
The diagnosis of ST-elevation myocardial infarction
(STEMI) is made from a history of acute-onset
chest pain, ST-elevation on ECG and subsequent
release of cardiac biomarkers suggesting myocardial
necrosis.1 Guidelines recommend urgent revascular-
isation, ideally with primary percutaneous coronary
intervention (PPCI) of the culprit artery.1 The
levels of biomarkers such as troponin are generally
not available at the time of revascularisation.
A subset of patients (2.6%–14%) with suspected
STEMI do not have a culprit lesion or obstructive
coronary artery disease (CAD) on the initial diag-
nostic coronary angiogram (DCA).2–5 Some of
these patients may have other non-atheromatous
cardiac or non-cardiac causes for their symptoms
and ECG abnormalities as well as biomarker
release.6 7 In the last few years, there has been an
increasing interest in alternative causes of acute
chest pain associated with troponin rise particularly
with non-invasive diagnosis of myocarditis on
cardiac magnetic resonance (CMR) or demonstra-
tion of myocardial infarction (MI) in the presence
of recanalised arteries.8–10 However, such studies
have mainly focused on small series of patients pre-
senting within a broader spectrum of acute coron-
ary syndrome (ACS) with raised troponin with the
aim of evaluating the usefulness of CMR. The
prevalence of non-coronary causes of acute chest
pain and their prognosis, particularly those present-
ing with suspected STEMI, is less well described.
The aim of this study was to determine the
prevalence and outcome of different cardiac and
non-cardiac conditions as identiﬁed on multimodal-
ity imaging in a large cohort of patients presenting
with suspected STEMI, who had no culprit lesion
on the angiogram.
METHODS
Patient recruitment
Our institution is a tertiary cardiothoracic centre
with an established 24-hour PPCI service with a
catchment population of about 2 million people.
Patients with suspected STEMI on the basis of clin-
ical signs and symptoms, and 12-lead ECG are
transferred directly by the ambulance service (diag-
nosis made autonomously in the ﬁeld without the
use of teletransmission) to our centre for consider-
ation of PPCI.11 Patients on arrival are reviewed by
the on-call cardiology team on site to conﬁrm the
diagnosis and proceed to PPCI, if appropriate.
Some patients are also transferred from nearby
general hospitals, if they are found to have suffered
a STEMI.
Consecutive patients who were admitted to the
PPCI programme between 1 January 2009 and 31
December 2012 were identiﬁed from the pro-
gramme registry (n=5238). Patients were excluded
as per the criteria shown in ﬁgure 1. All patients
without a culprit lesion on angiogram and no
known CAD were included in the study. Absence of
a culprit lesion was deﬁned as absence of a signiﬁ-
cant stenosis (>70% luminal narrowing) in the
vessel supplying the area of acute ECG change.
Known CAD was deﬁned as history of previous
ACS, PCI or coronary artery bypass surgery.
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The National Health Service ethics approval was obtained from
the hospital’s research department (Project ID: 199060).
Data collection and imaging indications
Patient demographics, traditional risk factors for CAD and present-
ing ECG as recorded in the database were identiﬁed. For all
included patients, the highest initial troponin result during the
admission was recorded (Access AccuTnI assay, Beckman Coulter,
Brea, CA, USA) from laboratory results in the electronic patient
records (EPR). The different non-invasive imaging procedures per-
formed as a result of the primary admission episode, their ﬁndings
and subsequent management were recorded from the hospital
Picture Archiving and Communication System and the EPR.
Images were not reviewed in all cases unless there was uncertainty
about a diagnosis or clariﬁcation was required. Our hospital has a
protocol for routine performance of plain chest X-rays (CXR) and
echocardiograms for all PPCI admissions once the patient is stable.
CMR is performed in those with non-obstructed coronary arteries
on DCA and unexplained rise in troponin or if required from echo-
cardiogram ﬁndings. A chest or ECG-gated cardiac CT is per-
formed if clinically indicated in patients with suspected pulmonary
embolism (PE), acute aortic dissection, pericarditis or other coron-
ary abnormality not identiﬁed on initial DCA. All imaging was per-
formed within the acute admission with follow-up scans as
required.
Imaging equipment and protocol
Echocardiography was performed on different commercially
available ultrasound machines (Vivid-7 or 9, GE Healthcare,
Milwaukee, WI, USA and IE33, Phillips Healthcare, Andover,
MA, USA). CT scans of the chest or ECG-gated scans of the
heart were carried out on a 64-slice scanner (Aquilion 64,
Toshiba Medical Systems, Japan). CMR scans of the heart were
performed on a cardiac optimised 1.5T system (Avanto, Siemens
Medical Systems, Germany). Standard protocols were used for
all imaging as recommended and described by various soci-
eties,12–14 with echocardiograms being performed by British
Society of Echocardiography certiﬁed sonographers and cardiol-
ogists. CT and CMR interpretation was carried out by level 3
certiﬁed cardiothoracic radiologists (TKM, BA) and/or imaging
cardiologists ( JW, SR-H).
Imaging diagnostic criteria and outcome
All imaging diagnoses (called primary diagnosis) were made
according to standard criteria using one or more imaging
modalities and classiﬁed under a broader diagnostic category. In
some patients, additional imaging ﬁndings were recorded if they
were considered important and not being a result of the
primary diagnosis.
Myocarditis was diagnosed on CMR as per the Lake Louise
consensus criteria based on T2-weighted oedema and late gado-
linium enhancement (LGE) sequences.15 A diagnosis of pericar-
ditis was made in the presence of a pericardial effusion or
thickening on any imaging modality in the absence of other
ﬁndings. MI was diagnosed if there was a typical LGE pattern
on CMR involving the subendocardium.16 Dilated cardiomyop-
athy (DCM) was deﬁned as left ventricular (LV) dilatation with
generalised hypokinesia and ejection fraction (EF) of <50% in
the absence of CAD or valvular disease.17 Hypertrophic cardio-
myopathy (HCM) was diagnosed in the presence of unexplained
myocardial thickness of ≥15 mm on echocardiography and
CMR in the absence of another cardiac or systemic disorder
that could explain the hypertrophy.18 A diagnosis of Takotsubo
cardiomyopathy (TTCM) was made when there was dilatation
and dysfunction of the distal half of the LV on ventriculogram,
which normalised on subsequent imaging scan in the absence of
MI or other signiﬁcant pathologies.19 Hypertensive heart
Figure 1 Flow chart showing exclusion criteria and ﬁnal patient
population included in the study. CABG, coronary artery bypass
surgery; CAD, coronary artery disease; MI, myocardial infarction; PCI,
percutaneous coronary intervention; PPCI, primary percutaneous
coronary intervention; STEMI, ST-elevation myocardial infarction.
Table 1 Patient characteristics and imaging performed
Number (n=575) Percentage
Age, mean (±SD) 57.7 (15.2)
Sex, male (%) 397 69
Hypertension 196 34.1
Dyslipidaemia 139 24.2
Current smoking 114 19.8
Diabetes 74 12.9
Family history of premature CAD 112 19.5
Out-of-hospital cardiac arrest 14 2.4
ST-elevation/LBBB on ECG 381 66.3
Troponin raised 229 39.8
Troponin, median (IQR) 0.48 (0.11, 4.0)
Chest X-ray 370 64.4
Echocardiogram 422 73.4
CT scan 100 17.4
CMR scan 147 25.6
EF <50%* 75 13.0
CMR LGE 72 12.5
*On either echocardiogram or CMR.
CAD, coronary artery disease; CMR, cardiac magnetic resonance; EF, ejection fraction;
LBBB, left bundle branch block; LGE, late gadolinium enhancement.
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disease was deﬁned as concentric myocardial thickening
>12 mm associated with systolic and/or diastolic dysfunction in
patients with a known long-standing history of hypertension or
newly diagnosed persistent hypertension for the purpose of this
study.20 Different valvular diseases were included if they were
found to be severe in degree as per guidelines.21 Pulmonary
infection was deﬁned as air space shadowing on the CXR or
CT, associated with raised inﬂammatory markers. Filling defects
in the pulmonary arteries on CT pulmonary angiogram were
diagnostic of PE. Aortic pathology included patients with
imaging ﬁndings of acute aortic dissection (type A or B), intra-
mural haematoma or unknown dilatation of the aortic root and/
or thoracic aorta of ≥5 cm in maximum diameter.
Finally, patient outcome was determined as all-cause mortality
from UK’s Health & Social Care Information Centre, which
tracks deaths of people residing within the country and regis-
tered with a general practitioner. Cause of death was identiﬁed
from hospital records and general practitioners.
Statistical methods
Continuous variables that were normally distributed are
expressed as mean±SD. Other continuous variables such as
troponin levels that were not normally distributed are described
as median with interquartile range and their groups were ana-
lysed using Mann-Whitney test. Categorical variables are
expressed as percentages and the χ2 test was performed for ana-
lysis. A two-tailed p value of <0.05 was considered statistically
signiﬁcant.
Cox regression with univariable and multivariable analyses
was performed to examine factors associated with survival
Table 2 Primary imaging diagnosis
Number (n=575) Per cent* Per cent† Age, mean±SD % Male‡ Raised troponin‡ (%)
Died‡
n=40 (%)
Imaging diagnosis
No imaging 76 13.2 NA 57±15 72 0 0
Imaging but no diagnosis 262 45.6 NA 57±15 77 58 (22) 13 (5)
Imaging with diagnosis 237 41.2 NA 59±15 59 171 (72) 27 (11)
All cardiomyopathy 104 18.1 43.9 60±14 52 71 (68) 9 (9)
Hypertrophic cardiomyopathy 28 4.9 11.8 55±11 82 15 (54) 2 (7)
Dilated cardiomyopathy 18 3.1 7.6 54±16 67 13 (72) 2 (11)
Takotsubo cardiomyopathy 27 4.7 11.4 70±10 4 23 (85) 3 (11)
Hypertensive cardiomyopathy 10 1.7 4.2 61±14 70 7 (70) 0
LVD with tachyarrhythmia or bradyarrhythmia 6 1.0 2.5 61±14 50 5 (83) 1 (17)
LVD with LBBB 4 0.7 1.7 51±17 50 0 0
LVD of non-specific aetiology 10 1.7 4.2 58±13 60 7 (70) 1 (10)
Myopericarditis 48 8.4 20.3 51±17 71 40 (83) 2 (4)
Myocarditis 36 6.3 15.2 47±16 69 35 (97) 1 (3)
Pericarditis 13 2.3 5.5 63±14 69 6 (46) 1 (8)
MI/coronary abnormality 27 4.9 11.4 53±11 71 27 (93) 1 (4)
MI 21 3.6 8.9 53±11 76 21 (100) 1 (5)
Anomalous coronaries 2 0.3 0.8 58±7 100 1 (50) 0
Coronary spasm 3 0.5 1.3 56±16 33 2 (67) 0
Coronary artery dissection 1 0.2 0.4 46±0 0 1 (100) 0
Valve disease, severe 23 4.0 9.7 71±13 43 17 (74) 8 (35)
Aortic valve stenosis 16 2.8 6.8 72±14 38 12 (75) 5 (31)
Aortic valve regurgitation 4 0.7 1.7 71±11 75 3 (75) 2 (50)
Mitral valve disease 3 0.5 1.3 66±19 33 2 (67) 1 (50)
Cardiac other 3 0.5 1.3 73±21 33 2 (67) 1 (33)
Pulmonary hypertension 2 0.3 0.8 86±5 0 1 (50) 1 (50)
PFO 1 0.2 0.4 48±0 100 1(100) 0
Aortic abnormality 6 1.0 2.5 54±12 68 2 (33) 2 (33)
Aortic dissection 4 0.7 1.7 56±15 75 2 (50) 2 (50)
Aortic aneurysm 2 (3§) 0.3 0.8 50±4 50 0 0
Pulmonary abnormality 23 4.0 9.7 64±14 68 14 (56) 3 (13)
Infection 12 (5§) 2.1 5.1 67±12 92 5 (42) 2 (17)
Pulmonary embolism 7 1.2 3.0 58±14 43 6 (86) 0
Pulmonary neoplasia 3 (2§) 0.5 1.3 67±3 67 2 (67) 1 (33)
Pneumothorax 1 0.2 0.4 35±0 100 0 0
Abdominal abnormality 3 0.5 1.3 72±17 33 1 (33) 1 (33)
Cholecystitis 2 0.3 0.8 70±23 50 1 (50) 0
Pancreatitis 1 0.2 0.4 77±0 0 0 1 (100)
*Percentages are from all patients included in the study group (n=575).
†Percentages are from all patients with imaging diagnosis (n=237).
‡Percentages represent proportion of patients from the same diagnostic category.
§Represent number of diagnosis additional to the primary diagnosis in some patients.
LBBB, left bundle branch block; LVD, left ventricular dysfunction; MI, myocardial infarction; NA, not applicable; PFO, patent foramen ovale.
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times. All variables were entered into the multivariable analysis
regardless of statistical signiﬁcance. Data were collected from all
patients for all variables except for EF, which was only available
for 429 patients from echocardiography and CMR.
Kaplan-Meier survival graphs were drawn with survival times
measured from the time of acute presentation to the time of
death. Patients who did not die were censored at the time of last
follow-up. Assumptions of proportional hazards were checked
by graphing −In{−In(survival)} against In(analysis time).
All statistical analysis was performed using Stata V.13.1
(StataCorp LP, College Station, TX, USA).
RESULTS
During the 4-year study period, 575 patients (13.0%) fulﬁlled
the inclusion criteria. The mean age of the included patients
was 57.7 years (±15.2) with 397 (69%) being men. Two
hundred twenty-nine patients (39.8%) had a raised troponin.
Other baseline characteristics are given in table 1.
A total of 499 patients (86.8%) had one or more imaging
procedure performed with a speciﬁc imaging-based diagnosis
made in 237 patients (41.2%) (table 2). Besides, there were 10
additional important ﬁndings including 3 cases of aortic aneur-
ysm, 5 cases of pulmonary infection and 2 cases of additional
pulmonary cancers that were present apart from the primary
diagnosis (table 2).
The different imaging modalities used for the various diag-
nostic categories are given in table 3. Multiple imaging techni-
ques were used in most cases as thought to be appropriate to
arrive at a diagnosis.
Out of the patients who had one or more imaging test per-
formed, 229 (46%) were troponin positive (TP). Among these,
an imaging diagnosis was made in 171 patients (74.7%). One
hundred twenty-two (53%) TP patients underwent CMR scan
as the rest either had diagnosis made from other imaging techni-
ques or were considered unsuitable (due to low clinical risk or
contraindications). The TP patients who did not undergo a
CMR scan and had no diagnosis made on other imaging modal-
ities had a much lower troponin level (median 0.095±0.48 vs
1.58±11.55 in those with diagnosis, p<0.0001). Of the 270
(54%) troponin-negative patients, an imaging diagnosis was
made in 66 patients (24.4%).
A total of 40 deaths (7.0%) from all causes occurred during a
mean follow-up of 42.6±17 months with mortality varying
widely between different conditions (table 2). Twelve of these
deaths occurred within 30 days giving a 30-day all-cause mortal-
ity rate of 2.1%. Different causes of death and mean time to
death is given in table 4. Cox regression revealed that on multi-
variate analysis, only age, out-of-hospital cardiac arrest (OHCA)
and EF<50% were signiﬁcantly associated with survival times
(table 5). None of the patients with LGE on CMR died.
Kaplan-Meier survival curves demonstrating the effect of signiﬁ-
cant variables on survival are given in ﬁgure 2.
DISCUSSION
Our study demonstrates the prevalence of alternative diagnoses
in patients admitted with suspected STEMI who had culprit-free
coronary arteries on angiography and no known CAD. This is
the largest study of patients presenting to a large PPCI pro-
gramme with further clinically directed but comprehensive mul-
timodality non-invasive imaging. It demonstrates that just under
half the patients are discharged with an alternative diagnosis,
some of which are potentially associated with an adverse
outcome. However, not all the diagnoses may be responsible for
patients’ presentation and some could be purely coincidental.
The prevalence of culprit-free coronary arteries in our patient
cohort (13.0%) is similar to that described in some studies,4 5
while other studies have reported a lower rate of up to 5%.2 3
This variation can be attributed to the local arrangements for
PPCI referral including the use of teletransmission in some
centres and differences in patient population. Like in our hospi-
tal’s protocol, where the patients are brought straight on the
basis of initial diagnosis of STEMI made by the trained ambu-
lance crew, the risk of false primary activation has to be weighed
against that of missing a true STEMI. This would explain the
presence of substantial number of troponin-negative patients in
our cohort.
Cardiomyopathies formed the most prevalent group of alter-
native diagnosis in our study population (18.1%). This was a
heterogeneous group, with HCM being the most common,
followed by DCM, TTCM and hypertensive heart disease.
HCM is well known to be associated with myocardial ischaemia
due to morphological abnormalities of the intramural coronary
arterioles22 23 and is the most common cause for sudden cardiac
death in the young.18 However, presence of ischaemia in HCM
is under-investigated in clinical practice and prevalence of HCM
in patients presenting with suspected STEMI has been
unknown.
Existence of TTCM has increasingly been recognised in
patients presenting with ACS. TTCM was equally prevalent as
HCM in our study cohort. Eitel et al24 reported 38 patients
Table 3 Imaging modalities used for different diagnostic categories
Imaging
diagnosis
Number
(n=499) CXR (%)* ECHO (%)* CT (%)* CMR (%)*
Imaging but no
diagnosis
262 200 (76) 196 (75) 38 (15) 28 (11)
Cardiomyopathy 104 71 (68) 100 (96) 15 (14) 55 (53)
Myopericarditis 48 34 (71) 47 (98) 12 (25) 37 (77)
MI/coronary
abnormality
27 15 (56) 27 (100) 6 (22) 20 (74)
Valve disease 23 19 (83) 23 (100) 6 (26) 2 (9)
Pulmonary
abnormality
23 22 (96) 18 (78) 15 (65) 2 (9)
Aortic
abnormality
6 4 (67) 5 (83) 3 (50) 2 (33)
Others 6 5 (83) 6 (100) 5 (83) 1 (17)
*All percentages are from the diagnostic category in the row itself. More than one
modality was used for diagnosis where appropriate.
CMR, cardiac magnetic resonance; CXR, chest X-ray; ECHO, echocardiogram; MI,
myocardial infarction.
Table 4 Different causes of death and average time to death
Cause of death Number, n=40 (%) Time to death in months (±SD)
Cardiac arrest 8 (20) 5.5 (±8.5)
Heart failure 15 (37.5) 10.6 (±13.8)
Myocardial infarction 1 (2.5) <1
Stroke 6 (15) 13.4 (±15.6)
Pulmonary embolism 1 (2.5) <1
Cancer 4 (10) 14.3 (±15.1)
Pulmonary infection 3 (7.5) 19.0 (±17.9)
Renal failure 1 (2.5) 9.1
Unknown 1 (2.5) 3.1
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with conﬁrmed diagnosis of TTCM with CMR in 6100 patients
presenting with ACS, but did not specify the number of patients
with non-culprit angiogram to make a comparison. In a systemic
review of previous studies, Gianni et al25 reported an average
prevalence of 2% in both Caucasian and Japanese populations
presenting with ACS.
DCM was the third most common cardiomyopathy in our
study. Existence of DCM has been described in patients with
ACS in other studies,2 9 26 but in much smaller numbers.
The diagnosis of DCM in this patient group may be coinciden-
tal, but would be relevant in view of adverse prognosis.
The second most common group of diagnosis was myoperi-
carditis, but myocarditis itself was the most common condition
(6.3% in all patients and 15.2% in TP patients). Studies that
have mainly focused on the usefulness of CMR in patients with
normal angiograms, without reference to the total number of
patients with culprit-free angiograms, usually report a much
higher prevalence of myocarditis, varying between 50% and
80%,8 9 26 although one study reports a prevalence of 16%.10 A
study by Larson et al,4 which is more similar to ours demon-
strated myocarditis in 19% of patients. However, the prevalence
of clinical myocarditis is likely to be higher as CMR criteria
have a sensitivity of up to 70%.15 27
The diagnosis of MI in the absence of culprit disease on the
angiogram has been made possible with LGE on CMR. The
prevalence of MI demonstrated in studies4 8–10 26 comprising
TP ACS patients varies from 5% to 23% (mean=13.5%), which
is similar to our patient cohort (13.6%) if only patients who
underwent CMR are included. These patients had a low mortal-
ity rate in the follow-up period (table 2).
Among the valve diseases, severe aortic valve stenosis (AVS) is
well known to present with symptoms of angina. The preva-
lence of AVS in patients presenting as ACS for PPCI is not well
known with two studies describing a single case each.3 4 A
prevalence of 2.8% (n=16) is possibly the highest reported with
75% having raised troponin.
Pulmonary abnormalities including embolism as the primary
diagnosis formed the fourth largest group. Pulmonary infection
was the most common followed by PE, both of which are
accepted causes of raised troponin.6 The cases of lung tumours
picked up on the CXR are likely to be coincidental, but would
have a deﬁnite bearing on patient management and prognosis.
Table 5 Predictors of all-cause mortality
Univariable analysis Multivariable analysis*
Variable HR (95% CI) p Value HR (95% CI) p Value
Age† 1.41 (1.14 to 1.75) 0.002 1.39 (1.09 to 1.77) 0.007
Male sex 0.82 (0.43 to 1.56) 0.54 1.51 (0.71 to 3.20) 0.28
High cholesterol 0.78 (0.36 to 1.69) 0.53 0.77 (0.33 to 1.82) 0.56
Hypertension 0.92 (0.48 to 1.79) 0.81 0.85 (0.39 to 1.85) 0.68
Smoking 0.10 (0.01 to 0.72) 0.02 0.16 (0.02 to 1.18) 0.07
Diabetes 1.44 (0.64 to 3.25) 0.38 1.23 (0.50 to 3.01) 0.65
OHCA 10.0 (4.19 to 23.9) <0.001 4.10 (1.41 to 11.9) 0.01
Raised troponin 2.95 (1.54 to 5.66) 0.001 1.14 (0.51 to 2.54) 0.75
EF <50%† 3.79 (1.98 to 7.26) <0.001 2.97 (1.45 to 6.07) 0.003
*Univariable EF and multivariable analysis based on 410 subjects, due to missing EF
data.
†HR reported for a 10-year increase in age.
EF, ejection fraction; OHCA, out-of-hospital cardiac arrest.
Figure 2 Kaplan-Meier survival curves (A) for the whole study group, (B) by age groups, (C) by out-of-hospital cardiac arrest (OHCA) and (D) and
by ejection fraction (EF).
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Acute aortic syndromes are well-known causes of acute chest
pain with an incidence of about 6 per 100 000 persons per year
in a recent study.28 While the majority are identiﬁed with the
appropriate clinical features and imaging, about 10% cause cor-
onary obstruction and thus present as STEMI.29 The patients
included in our study did not have coronary obstruction as
patients with latter have been excluded. Lastly, a number of
acute abdominal conditions including cholecystitis, pancreatitis
and rupture of abdominal aortic aneurysms are known to mimic
STEMI. The prevalence of these conditions is low, but early
identiﬁcation with imaging and management is important.
A substantial proportion of patients (45.6%) in our study
cohort did not have any other diagnosis made on clinically
guided imaging, although all of them had abnormal ECGs and
clinical history sufﬁcient enough to warrant primary activation
and undergo DCA. Fifty-eight of these patients also had mild rise
in troponin level raising the possibility of microemboli causing
myocardial necrosis, but with partial or complete recanalisation
of the coronary arteries, or due to coronary embolism or spasm.9
If CMR with LGE was performed in all these patients, it is pos-
sible that some may have demonstrated areas of MI.
The study cohort contains a group of patients with heteroge-
neous diagnoses and hence a variable prognosis. The all-cause
mortality was worse in patients with severe AVS, aortic dissec-
tion and pulmonary neoplasia, while benign in those with myo-
carditis. The patient with myocarditis who died was diagnosed
to have giant-cell myocarditis on endocardial biopsy, which is
known to have a poor outcome. However, irrespective of the
diagnosis, increasing age, presentation with OHCA and EF of
<50% were associated with worse outcomes. All deaths in
patients with OHCA occurred within 35 days of presentation,
resulting in an excellent late survival (60%) in those who sur-
vived (ﬁgure 2C).
Limitations
The limitations of our study pertain to its retrospective observa-
tional nature. Not all patients had every type of non-invasive
imaging, which would be impractical in a clinical set up. This
may have led to underestimation of prevalence for certain con-
ditions such as myocarditis and infarction; non-invasive diagno-
sis of which is particularly dependent upon CMR. However, we
think that this underestimation would be low as the troponin
levels were much lower in patients who did not undergo CMR
imaging. Also even though not all patients underwent an
echocardiogram, a ventriculogram was performed in every
patient during DCA. This allowed identiﬁcation of LV dysfunc-
tion from TTCM and other causes. Therefore, our ﬁndings are
representative of a real-life scenario rather than a uniﬁed con-
trolled approach throughout a study group. Based on our
experience, we suggest a pathway for non-invasive imaging in
this patient cohort (ﬁgure 3).
In conclusion, just under half of patients with suspected
STEMI with a culprit-free coronary angiogram and no history
of previous CAD have an alternate diagnosis made with multi-
modality imaging. These diagnoses are heterogeneous involving
both cardiac and non-cardiac abnormalities with a variable prog-
nosis. The use of non-invasive imaging techniques in this group
of patients is, therefore, helpful as otherwise important ﬁndings
could be missed and go untreated.
Figure 3 Flow chart of suggested
non-invasive imaging pathway in
patients with suspected STEMI but no
obstructive CAD. CAD, coronary artery
disease; CXR, chest X-ray; CMR,
cardiac magnetic resonance; ECHO,
echocardiogram; STEMI, ST-elevation
myocardial infarction.
Key messages
What is already known on this subject?
▸ A proportion of patients with suspected ST-elevation
myocardial infarction (STEMI) with no obstructive coronary
artery disease have other diagnosis, which could be
identiﬁed with one or more imaging techniques.
▸ There is a high prevalence of myocarditis in this patient
cohort as identiﬁed on cardiac MRI studies.
What might this study add?
▸ About 13% of patients presenting with suspected STEMI
may not have obstructive coronary artery disease. The most
common alternative diagnosis in these patients as identiﬁed
on multimodality imaging include cardiomyopathies (18%),
myopericarditis (8.4%), myocardial infarction without
coronary artery obstruction (4.9%), severe valve disease
(4%), pulmonary embolism (1.2%) and type A aortic
dissection (0.7%).
▸ Some of the conditions have an adverse prognosis.
How might this impact on clinical practice?
▸ Diagnosis of alternative diagnosis with imaging in patients
with suspected STEMI can be important to implement
appropriate management strategies.
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